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Abstract
The reporter gene for ß-galactosidase is frequently used
to determine the efficiency of gene transfer in arteries.
However, blood is often present in arterial explants and
may compromise the results by the presence of hemo-
globin. The light absorption of hemoglobin is similar to
the absorption of several colorimetric products of the
commonly used ß-galactosidase substrates, including o-
nitrophenyl-ß-D-galactopyranoside (ONPG) and chloro-
phenol red galactopyranoside (CPRG). This may result in
false-positive measurements of ß-galactosidase enzyme
activity. The aim of this investigation was to determine
the most appropriate method for quantification of ß-ga-
lactosidase activity in the presence of blood. Colorimet-
ric substrates (ONPG, CPRG) or the chemiluminescent
Galacton-Plus substrate were used, and light absorption
was measured at different concentrations of erythrocyte
extract. Among the ß-galactosidase substrates tested,
CPRG was the most appropriate, allowing detection of
enzyme activity at concentrations as low as 0.05 mU,
independent of blood contamination. Addition of reduc-
er stabilized enzyme activity for at least 5 h. Endogenous
ß-galactosidase activity was evaluated and used to cor-
rect results. CPRG substrate, in combination with the
reducer agent mercaptoethanol, was found to be the
optimal reagent for quantifying ß-galactosidase activity
in the presence of blood after nonviral in vivo reporter
gene transfection, even with a relatively low transfer effi-
ciency.
Copyright © 2000 S. Karger AG, Basel
Introduction
The reporter gene ß-galactosidase is frequently used to
determine transfection efficiencies in cell cultures or tis-
sues. The administration of the gene for ß-galactosidase
and the detection methods to assess the protein product
are relatively simple and cost-effective. Transfected cells
may be identified in situ by blue staining, which results
when the substrate 5-bromo-4-chloro-3-indolyl-ß-D-ga-
lactopyranoside is converted by the expressed ß-galactosi-
dase into 5-bromo-4-chloro-3-hydroxyindol. For quanti-
tative evaluations, ß-galactosidase expression is usually
analyzed using colorimetric assays, which measure en-
zyme activity. Several substrates are available for colori-
metric assays, including o-nitrophenyl-ß-D-galactopyra-
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noside (ONPG [1]) and chlorophenol red galactopyrano-
side (CPRG [2, 3]). In addition, several highly sensitive
chemiluminescence assays are now available for measur-
ing light emission, for example Galacton-LightTM or
Galacton-Light PlusTM [4, 5] (Tropix, Bedford, Mass.,
USA).
Blood is frequently present in tissue samples, particu-
larly when tissues derive from arteries or other blood ves-
sels. Hemoglobin, found in erythrocytes and blood, has an
absorption spectrum between 400 and 600 nm, with a
maximum between 520 and 580 nm. Hence, the light
absorption of hemoglobin is similar to the absorption of
ß-galactosidase products, which results from 400–430 nm
for ONPG and from 540–590 nm for CPRG. This may
result in false-positive measurements of ß-galactosidase
enzyme activity. For vascular nonviral gene transfer ex-
periments in vivo, transfer efficiencies are commonly less
than 1%. Furthermore, each tissue sample may contain
unpredictable amounts of blood. Therefore, quantitative
analysis using these substrates might not be interpretable
or reproducible.
In this paper, a photometric method that allows accu-
rate quantification of ß-galactosidase activity, even in the
presence of blood contamination, is described in trans-
fected primary cultures of porcine smooth muscle cells
(SMCs) and transfected porcine arteries.
Methods
Cell Culture
Primary cultures of porcine SMCs were isolated from explants of
pig arteries and cultured in medium (equal volumes of HAM, Bio-
chrom KG, Berlin, Germany and Waymouth, Gibco BRL, Eggen-
stein, Germany) with 10% fetal calf serum, 4 mM glutamine, 100 U
penicillin, 100 Ìg/ml streptomycin and 2.5 mg/ml amphotericin B as
previously described [6]. SMCs from the first 4 passages were used.
Tissue Samples
Fresh tissue samples taken from various organs obtained from
normal pigs were analyzed for endogenous ß-galactosidase. Tissue
specimens were divided, rapidly snap-frozen in liquid nitrogen and
stored at –80°C. Samples were later homogenized and resuspended
in 200 Ìl of lysis buffer (100 mM potassium phosphate, pH 7.8, 0.2%
Triton X-100); mercaptoethanol (100 mM) was added fresh prior to
use. Samples were centrifuged at 15,000 rpm for 15 min and the
supernatant (protein extract) was used for further experiments.
Optical Density Measurement
Optical density was measured in erythrocyte extract supple-
mented with bovine serum albumin or SMC extract. Erythrocyte
extract was prepared by centrifugation of human blood at 5,000 rpm
for 10 min. The lowest layer, containing erythrocytes, was mixed
with lysis buffer (1:1, v/v) and the protein concentration was deter-
mined using the bicinchoninic acid protein assay (Pierce, St. Augu-
stin, Germany). SMC protein extract was prepared by trypsinization
of cell cultures, centrifugation and resuspension in 100 Ìl of lysis
buffer. Optical density was quantified at the wavelengths used for
quantitative ß-galactosidase assays. Absorption was measured at
405 nm for ONPG and 540 nm for CPRG using samples of 10–
100 Ìg protein from erythrocyte extracts made up of 100 Ìg of total
protein with either bovine serum albumin or SMC protein extract to
exclude any influence of other cellular proteins.
Measurement Using Colorimetric Substrates
For quantification of ß-galactosidase gene expression, samples
were prepared on 96-well plates in duplicates. Extracts containing
100 Ìg protein contaminated with blood were diluted in 50 Ìl lysis
buffer. The two colorimetric substrates were CPRG and ONPG. In
the first part of the experiment, carried out without substrate, 150 Ìl
of HBSS (Hanks’ balanced salt solution) were added; in the second
part of the experiment, the substrate was used instead. CPRG: 150 Ìl
of CPRG substrate (1 mg/ml in HBSS) were added; at 30 min, 1, 2, 3
and 4 h following the addition of HBSS or CPRG, consecutive mea-
surements of the optical density at 540 nm were performed. ONPG:
150 Ìl assay buffer containing the ONPG substrate, prepared accord-
ing to the manufacturer’s protocol (Promega, Munich, Germany),
were added and incubated at 37°C for 30–120 min. The optical den-
sity was measured at 405 nm. The reference wavelength for the
ELISA reader (Titertek Multiscan MCC/340, EFLAB, Helsinki, Fin-
land) was 690 nm. Activity was calculated using known enzyme
activity of ß-galactosidase (Promega) and corrected for any activity
from nontransfected SMCs.
Measurement Using Chemiluminescent Substrate
Galacton-Plus substrate (Roche, Ingelheim, Germany) was di-
luted to make reaction buffer as described according to the manufac-
turer’s recommendations. Aliquots of 2–20 Ìl of the 100 Ìg protein
extract were supplemented to a total volume of 20 Ìl with lysis buff-
er. Reaction buffer (200 Ìl) was added to a luminometer cuvette,
gently mixed with the protein extract and incubated at room temper-
ature for 60 min. The cuvette was placed in a luminometer (Lumat
LB9507, Berthold, Pforzheim, Germany), and 300 Ìl of light emis-
sion accelerator were injected. Five seconds following this injection,
light emission was quantified for 10 s. Measurements were obtained
in the presence or absence of erythrocyte extract.
Calculation of ß-Galactosidase Activity in the Presence of Blood
Erythrocyte extract samples of 10–100 Ìg were supplemented
with SMC protein extract to 100 Ìg protein. Optical densities at
540 nm were determined for each concentration of blood. Results
were illustrated in a graph (fig. 1a). The optical density of the blood-
contaminated samples (ODblood) was measured without substrate and
corrected for background absorption without blood. At the optical
density of a sample without substrate (ODblood), the blood content
(BC) in the sample was determined on the x-axis. The measured opti-
cal density of the same sample with CPRG substrate (ODsample) was
then corrected by subtracting ODblood. This value was divided by
(1 – BC) to obtain the optical density of the sample corrected for
blood contamination (ODß-gal) for 100 Ìg tissue protein:
ODß-gal = (ODsample – ODblood)/(1 – BC),
where ODß-gal = calculated specific optical density of the transfected
ß-galactosidase corrected for blood contamination and for 100 Ìg
ß-Galactosidase Activity in the Presence of
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total protein; ODsample = measured optical density of the blood-con-
taining sample with substrate; ODblood = measured optical density of
blood-containing sample without substrate, corrected for back-
ground absorption; (1 – BC) = factor correcting the calculated optical
density of ß-galactosidase for blood content per 100 Ìg total protein.
The optical density calculated as above was extrapolated on the
x-axis using the ß-galactosidase standard curve. This gave the specific
ß-galactosidase activity (fig. 1b). This value was further corrected by
subtracting endogenous ß-galactosidase activity.
Endogenous ß-Galactosidase Activity
The endogenous ß-galactosidase enzyme activity was determined
using 100 Ìg of protein extract from porcine SMCs in primary cul-
ture and from organs of nontransfected pigs. Enzyme activities were
measured and corrected for blood content as described above.
Transfection of Cell Cultures
To test the analytical method, primary cell cultures of porcine
SMCs were transfected with the gene for ß-galactosidase. Porcine
SMCs were seeded into 6-well plates 48 h before transfection
(100,000–200,000 cells/well). The cationic lipids DOCSPER [1,3-
dioleoyloxy-2-(N5-carbamoyl-spermine)-propane] [7] or Lipofect-
AMINE (Gibco, Eggenstein, Germany) complexed with the plasmid
pCMVß (Clontech, Heidelberg, Germany) were used for gene trans-
fer. The pCMVß plasmid (1 Ìg) and the liposomes (5 Ìg) were sepa-
rately each diluted in 100 Ìl of serum-free medium, then mixed and
incubated for 30 min at room temperature. SMCs were washed twice
with phosphate-buffered saline (PBS) and the wash buffer was dis-
placed with 800 Ìl serum-free medium. The transfection complex
was added drop-wise to the cells. After 4 h incubation time at 37°C
in 5% CO2, the medium was replaced with fresh medium including
10% fetal calf serum.
For the analysis of ß-galactosidase activity, cells were washed
with PBS 48 h following transfection and trypsinized for 5 min with
0.25% trypsin/PBS. Cell numbers were determined with a particle
counter (CASY 1, Schärfe System, Reutlingen, Germany). Cells were
suspended in 100 Ìl lysis buffer, centrifuged at 4°C and the superna-
tant was used for further experiments.
Transfection of Pig Arteries in vivo
Pig iliac arteries were transfected with pCMVß, and animals were
sacrificed after 1 week. The protocol has previously been published
[6]. All animal procedures were approved by the Animal Care and
Use Review Committee of the University of Marseille according to
French guidelines. Study animals were Pietrain pigs (average weight
35 kg at the initial procedure; n = 12). Anesthesia and balloon angio-
plasty in iliac arteries were performed as previously described [6].
Balloon catheters were introduced via 6-french intra-arterial sheaths
into femoral arteries and balloons of 4 cm length were inflated for 3
times at 8 atm for 1 min.
After deflation and withdrawal of the balloon in each femoral
artery of study animals 30 Ìg plasmid DNA with 300 Ìg DOCSPER
in 2 ml serum-free DMEM were deposited into two experimental
segments using a needle injection catheter (BMT, Oberpfaffenhofen,
Germany) as described [6]. Sacrifice took place 7 days after transfec-
tion, using the same anesthetic protocol, including orotracheal intu-
bation and mechanical ventilation. Blood samples, noninjured carot-
id arteries and skeletal muscle adjacent to the treated vessel and
organs (liver, lung, spleen, heart, small intestine and kidney) were
removed before arteries treated with plasmids using RNase-free
Fig. 1. Graph to determine specific ß-galactosidase activity of blood-
containing samples. a Optical density of samples containing different
erythrocyte extract concentrations in the presence ()) and absence
(o) of CPRG substrate and also with CPRG and a known ß-galacto-
sidase concentration (0.5 mU, X). All curves show approximately
linear dependence and are shifted in parallel. From this graph the
optical density of the sample containing blood (ODsample), the optical
density of the blood contamination (ODblood) and the amount of
blood in the sample (BC) can be determined. b ß-Galactosidase stan-
dard curve, from which the specific enzyme activity (Aß-gal) can be
extrapolated after the specific optical density (ODß-gal) has been cal-
culated. Data are means B SD from minimally 3 identical experi-
ments with determination performed at least in triplicate.
instruments were explanted. Vessels were then cross-sectioned start-
ing at the proximal site into 0.5-cm-thick segments and each second
segment was embedded in OCT compound (Miles Scientific, Elk-
hart, Ind., USA); the other tissue samples were snap-frozen.
Analysis of the ß-Galactosidase mRNA
Snap-frozen tissue was homogenized in liquid nitrogen and RNA
was prepared with RNAzol B reagent (CINNA/MRC, Cincinnati,
Ohio, USA). Total RNA (1–5 Ìg) was reverse transcribed employing
the T-Primed First-Strand cDNA Synthesis Ready To Go Kit (Phar-
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macia). A PCR was performed as previously described [6]. The quali-
ty of transcribed RNA was shown by amplification of the 5)-end of
the GAPDH gene transcript (GAPDH L1: 5)-CGTCTTCACCAC-
CATGGAAGAAGGC-3)/GAPDH R2: 5)-AAGGCCATGCCAGT-
GAGCTTCCC-3), 398 bp). For the detection of the transfected plas-
mids the following primers were used: ß-galactosidase b-gal L):
5)-GCATCATCCTCTGCATGGTCAG-3) and b-gal R1: 5)-AAA-
CCGCAAGACTGTTACCCATCG-3) (572 bp). Amplified DNA
fragments were analyzed by electrophoresis on 1.5% agarose gels.
Statistical Analysis
All values are expressed as means B standard error (SD) of 3 or 4
experiments for each condition. One-way ANOVA was used for com-
parison of differences among the groups (SPSS Inc., Chicago, Ill.,
USA). The statistical significance was defined as p ! 0.05.
Results
Optical Density of Erythrocyte Extracts 
The optical densities of different erythrocyte extract
concentrations (ranging from 10 to 100 Ìg) supplemented
with bovine serum albumin or SMC protein extract were
determined. The optical densities measured in erythro-
cyte extracts at the different concentrations were indepen-
dent of the presence of supplemented bovine serum albu-
min or SMC protein (data not shown).
Measurement Using Colorimetric Substrates
The optical densities of samples with different erythro-
cyte extract concentrations supplemented with protein
extract of SMCs were measured in the presence or ab-
sence of the ß-galactosidase substrates CRPG or ONPG.
Without substrate, the absorption was directly propor-
tional to the amount of erythrocyte extract applied, giving
rise to a linear curve (fig. 1). If CPRG substrate was added
to samples with the same concentrations of erythrocyte
extract, a second linear curve shifted parallel to the curve
without substrate appeared (fig. 1a). Addition of CPRG
and a known ß-galactosidase concentration (0.5 mU)
resulted in further parallel shifting of the curve on the y-
axis (fig. 1a). In contrast, addition of ONPG showed no
significant difference between curves with or without sub-
strate (fig. 2). The curve grades were steeper compared
with curves using CPRG substrate. Addition of ß-galacto-
sidase with 1.0 mU activity did not show any significant
shift of the curve. First higher ß-galactosidase enzyme
activity (5.0 mU) resulted in an almost parallel shift of the
curve. Without blood contamination, the use of the
ONPG substrate resulted in values proportional to those
obtained using the CPRG substrate. However, overall,
the use of ONPG demonstrated 20% lower ß-galactosi-
Fig. 2. Optical density of different erythrocyte extract concentra-
tions with ()) and without (X) ONPG substrate and also with a
known ß-galactosidase concentration (o = 1.0 mU, ! = 5 mU).
There was no parallel shift observed between the curves with and
without substrate with increasing concentrations of the erythrocyte
extract. Similar results were obtained with 1.0 mU of ß-galactosidase
enzyme activity. The shift of the curve was seen first at 5.0 mU. Val-
ues are means B SD. * p ! 0.05 for ONPG+/ß-Gal 5 mU versus
ONPG+; # p ! 0.05 for ONPG– versus ONPG+.
dase activities compared with the use of the CPRG sub-
strate for measurement.
Measurement Using Chemiluminescent Substrate
The Galacton-Plus substrate also demonstrated
changes in light emission in the presence of blood. Over-
all, luminescence values recorded using this substrate for
measurement of ß-galactosidase activity were 20–30%
lower when erythrocyte extract was added, independently
of the erythrocyte extract concentration. There was no
correlation between increasing erythrocyte extract con-
centrations and lowering of luminescence measured
(fig. 3).
Calculation of ß-Galactosidase Activity in the Presence
of Blood
Experiments using the CRPG substrate to measure ß-
galactosidase activity in SMC extracts were carried out
with known ß-galactosidase enzyme concentrations (0.05,
0.10 and 0.50 mU) with and without blood contamina-
tion. Optical densities of the samples and resulting ß-ga-
lactosidase activities were calculated as described in the
Methods section and are demonstrated in figure 1. Blood-
ß-Galactosidase Activity in the Presence of
Blood
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Fig. 3. Influence of blood contamination on the results using the
chemiluminescent substrate Galacton-Plus. The Galacton-Plus sub-
strate also demonstrated changes in light emission in the presence of
blood. The light emission was 20–30% lower comparing with sam-
ples without blood contamination independent of erythrocyte extract
concentrations. Values are given as means B SD. A significance of
p ! 0.05 was found for 0/100 (erythrocyte extract/whole protein, Ìg/
Ìg) versus all other groups (20/100, 40/100, 60/100, 80/100).
Fig. 4. Enzyme activity measured at known ß-galactosidase concen-
trations (0.05, 0.10 and 0.50 mU) in the presence of blood contami-
nation. ) = ß-Galactosidase enzyme activity values without correc-
tion; $ = activity values using the described method to correct for
presence of blood (see text). Duplicates or triplicates of 50 Ìg SMC
extract, 50 Ìg erythrocyte extract and a defined concentration of ß-
galactosidase were mixed to a total of 100 Ìg protein. Uncorrected
values resulted in 2–4 times higher enzyme activity recorded, com-
pared with corrected values. Calculated ß-galactosidase activities
yielded values that correlated with values expected (* p ! 0.05).
contaminated samples with known ß-galactosidase con-
centrations were compared with samples containing the
same ß-galactosidase amount without the presence of
blood. Results confirmed the accuracy of the method for
correcting for the presence of blood (fig. 4). Accurate val-
ues were obtained at concentrations of ß-galactosidase of
more than 0.05 mU. However, for samples with concen-
trations of ß-galactosidase of 0.05 mU or lower, there
were deviations of up to 40% of enzyme activity also with
correction. ß-Galactosidase activities obtained without
correction for blood contamination yielded values 2–4
times higher than those which were corrected (fig. 4).
Stabilization of ß-Galactosidase Activity Using
Reducing Agents
For these experiments protein extracts were made
using lysis buffer without mercaptoethanol. ß-Galactosi-
dase enzyme activities in samples without blood contami-
nation remained stable for at least 5–6 h also in the
absence of mercaptoethanol. Blood-containing samples
without reducer demonstrated their highest ß-galactosi-
dase activity 30 min following addition of the substrate.
This decreased rapidly over time (fig. 5a,b). Samples with
blood contamination but without reducer demonstrated
consistently higher enzyme activities than the known
enzyme activity of the ß-galactosidase added to the sam-
ple. In contrast, values for calculated ß-galactosidase ac-
tivity from blood-contaminated samples treated with the
reducing agent mercaptoethanol (100 mM, included in
the lysis buffer) remained stable, correlating well with the
known enzyme activity of the ß-galactosidase present in
the sample (fig. 6).
Endogenous ß-Galactosidase Activity
The endogenous ß-galactosidase activity in porcine
SMCs grown in primary cultures and in various porcine
organs from 5 animals was determined and corrected for
blood content (fig. 7). Endogenous ß-galactosidase activi-
ties calculated without correction for blood contamina-
tion demonstrated markedly higher values than the sam-
ples corrected for blood content. ß-Galactosidase activity
was dependent on the amount of blood in the sample
(data not shown). In extracts from porcine SMCs in pri-
mary culture, the endogenous activity for ß-galactosidase
was not detectable. Iliac arteries, carotid arteries and
heart and lung tissue demonstrated endogenous ß-galacto-
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Fig. 5. Time-dependent ß-galactosidase activity of blood-contami-
nated samples in the absence of reducer compared with expected val-
ues. a SMC extract mixed with 50 Ìl erythrocyte extract to a total
protein concentration of 100 Ìg and known ß-galactosidase enzyme
activity (0.05, 0.10, 0.50 mU). b Measurement of arterial tissue sam-
ples (carotid artery) contaminated with blood and known ß-galactosi-
dase enzyme activity. Both a and b demonstrated in the absence of
reducer decreasing ß-galactosidase enzyme activity progressively
over time. c Transfection of SMCs and addition of erythrocyte
extract to one part of the transfected samples. Without blood con-
tamination, there was stable enzyme activity throughout the mea-
surements. In contrast, transfected SMCs containing erythrocyte
extract without reducer treated similarly to a and b resulted also in
decreasing ß-galactosidase activity over the measurement period.
Values represent means B SD.
Fig. 6. Influence of reducing agents on the stability of ß-galactosidase
activity measurement in the presence of blood contamination (X =
without reducer, ) = with mercaptoethanol). SMC extract was mixed
with 50 Ìg of erythrocyte extract to a total protein content of 100 Ìg
and known concentrations of ß-galactosidase were added: 0.05 mU
(a), 0.10 mU (b) and 0.5 mU (c). Finally, mercaptoethanol (100 mM)
was supplemented. The reducing agent was able to stabilize the
enzyme activity during the whole measurement. Data are means B
SD from 3 experiments. Significant differences to the expected activ-
ity were marked (* p ! 0.05).
sidase activity of between 0.1 and 0.2 mU (iliac arteries
0.13 B 0.08 mU, carotid arteries 0.2 B 0.05 mU, heart
tissues 0.14 B 0.04 mU, lung tissues 0.2 B 0.06 mU). The
highest endogenous activity was obtained in kidney (4.3
B 0.8 mU), followed by liver (1.7 B 0.17 mU), intes-
tinal tissue (1.5 B 0.08 mU) and lymph nodes (0.3 B
0.6 mU).
ß-Galactosidase Activity in Transfected Cell Cultures
Transfection of SMCs in primary culture was per-
formed using the pCMVß vector containing the ß-galac-
tosidase gene. Measurement of the ß-galactosidase en-
zyme activity in cells without blood contamination using
the CPRG substrate demonstrated consistency in the val-
ues measured over a 4-hour time period after substrate
addition. In contrast, cultured SMCs supplemented with
10–100 Ìg protein of erythrocyte extract showed marked-
ly increased values, which were 10–30% higher (fig. 5c).
ß-Galactosidase Activity in the Presence of
Blood
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Fig. 7. Endogenous ß-galactosidase activity of tissue extracts from
various porcine organs. The organs analyzed (arteries, heart, lung,
liver, kidney, intestine, spleen and lymph nodes) were explanted
from 5 animals and proteins were extracted from specimens. From
each tissue 100 Ìg of protein was used to determine the ß-galactosi-
dase enzyme activity. Iliac arteries, carotid arteries and heart and
lung tissue showed relatively low values between 0.1 and 0.2 mU
(iliac arteries 0.13 B 0.08 mU, carotid arteries 0.2 B 0.05 mU, heart
tissue 0.14 B 0.04 mU, lung tissue 0.2 B 0.06 mU). Spleen and
lymph nodes achieved 0.2 B 0.05 and 0.3 B 0.06 mU. The highest
endogenous ß-galactosidase activity was demonstrated by intestine
(1.5 B 0.08 mU), liver (1.7 B 0.17 mU) and kidney (4.3 B 0.8 mU).
The values are means B SD from 5 independent samples performed
in triplicate.
Fig. 8. Transfection experiments in vivo: ß-galactosidase enzyme
activity (a) and ß-galactosidase gene expression (b). S1–S7 = Trans-
fected arterial segments; K1 = nontransfected tissue; K2 = pCMVß.
The uncorrected ß-galactosidase enzyme activity ()) demonstrated
significantly (* p ! 0.05) higher and even false-positive enzyme activ-
ities compared with the corrected results ($). ß-Galactosidase activi-
ty values corrected for the blood content correlated well with ß-galac-
tosidase gene expression using RT-PCR. Data are means B SD per-
formed in triplicate.
Calculated values decreased incrementally over time. Re-
sults were consistent with the previous experiments con-
ducted with extracts of SMC protein and addition of
known ß-galactosidase concentrations (fig. 4). Endoge-
nous ß-galactosidase activity was not detectable in cul-
tures of SMCs, and no further correction of values was
necessary.
ß-Galactosidase Activity in Transfected Tissues
Following a protocol previously described [6], trans-
fected pig iliac arteries were analyzed for expression of
ß-galactosidase gene using RT-PCR and ß-galactosidase
enzyme activity measurements. Results are summarized
in figure 8. Uncorrected ß-galactosidase activity values
were 0.5–5 times higher than the results corrected accord-
ing to the procedure described in this paper (fig. 8a).
Uncorrected ß-galactosidase activities were too high or
demonstrated also false-positive results (fig. 8a, segment
S7). In contrast, ß-galactosidase enzyme activities cor-
rected for blood content correlated well with the results
obtained by RT-PCR (fig. 8b).
Discussion
The hemoglobin within blood may significantly com-
promise results obtained when ß-galactosidase activity is
measured in arterial tissue samples. This is particularly
true when transfection efficiencies are low. This applies to
many cardiovascular gene transfer experiments per-
formed on arteries in vivo. In this paper, the influence of
the presence of blood contamination on ß-galactosidase
analyses was evaluated and a method for the correct
determination of enzymatic activity was established. This
method allows correction of errors resulting from the
presence of blood.
Addition of protein extract from BSA or from cultured
SMCs to different erythrocyte extract concentrations did
not result in any changes in optical density measured. It
can be concluded that other cellular proteins that may be
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contaminating do not influence the absorption properties
of blood-containing solutions.
Of the ß-galactosidase substrates tested, CPRG ap-
peared to be optimal for the determination of ß-galactosi-
dase activity in the presence of erythrocyte extract. Using
CPRG, a parallel shift of the curves for the optical densi-
ties of samples with and without substrate was observed.
The parallel shift may be explained by the specific absorp-
tion of CPRG, which evenly increases each value for opti-
cal densities obtained. Thus, the sample did not influence
the absorption of the substrate. The parallel shift allows
the actual activity to be calculated.
In samples with blood contamination, the concentra-
tion of erythrocytes may be obtained using the formula
proposed. The use of the formula was demonstrated to be
accurate by carrying out experiments using samples with a
known ß-galactosidase content and blood contamination.
The specific ß-galactosidase activity of samples obtained
using the CPRG substrate allowed measurements of en-
zyme activities to be determined down to levels as low as
0.05 mU, even in the presence of blood. Blood-contami-
nated controls with a known ß-galactosidase content ana-
lyzed using photometric ß-galactosidase methods without
the calculation procedure resulted in values, which were
too high or a false-positive enzyme activity measure-
ment.
The optical density of samples with unknown ß-galac-
tosidase activity consists in part of the optical density of
nontransformed substrate. Optical density of the ONPG
substrate without ß-galactosidase was reduced with in-
creased blood concentration of samples. This leads to
reduced ß-galactosidase activities compared to samples
without blood contamination. Although the calculation of
blood content was more exact due to steeper curve grades
at 420 nm compared to those at 540 nm, ß-galactosidase
activities as low as 1 mU could not be detected. For de-
termination of low ß-galactosidase enzyme activities
achieved in liposomal transfection experiments in vivo
the ONPG substrate is therefore not suitable.
The use of the Galacton-Plus substrate was also com-
promised by blood contamination when the samples with
known ß-galactosidase content were studied. The mea-
sured luminescence was reduced up to 30% following
addition of erythrocyte extract independent of erythro-
cyte extract concentration. Probably already a low con-
centration of erythrocyte extract led to saturation and
diminished the luminescence measured. Comparison of
values with different erythrocyte extract concentrations
did not result in interpretable data. Measurements in the
absence of the substrate were not possible as the lumines-
cence results from the substrate itself. Therefore, negative
controls with unknown blood amount cannot be in-
cluded.
In the absence of reducing agent calculated ß-galactosi-
dase activities also depended on the time point of mea-
surement following substrate addition to blood contami-
nating samples. The highest enzyme activities were found
30 min after substrate addition, which decreased progres-
sively over time. The oxidation state of hemoglobin in
samples without mercaptoethanol was time dependent
and could lead to variable optical densities. Using mer-
captoethanol, stabilization of light absorption in the sam-
ples was observed for at least 4 h. The calculated ß-galac-
tosidase activities corresponded to those measured in
samples without blood contamination. Therefore, reduc-
ing agent should still be added to blood-contaminated
samples, prior to start analyzing.
Blood and endogenous ß-galactosidase activity may
variably contribute to the activity deriving from gene
transfer in a range of 1–5 mU/100 Ìg protein. Using alter-
native gene transfer systems with relatively high efficien-
cy, such as adenoviral-mediated gene transfer, the trans-
fer efficiency is usually lower than 8 mU/100 Ìg protein
[8, 9]. Therefore, the error before correction for blood
contamination represents more than 15% of the measured
specific activity and can therefore significantly interfere
with the results obtained.
Analyses of tissue extracts from various porcine organs
demonstrated that arteries, heart tissue and lung tissue
had relatively low endogenous ß-galactosidase activity, of
about 0.1 mU. In contrast, liver, kidney and intestinal tis-
sue contained very high endogenous ß-galactosidase en-
zyme activity, up to 5 mU. Reporter enzyme activities in
transfected tissues should therefore additionally be cor-
rected for the endogenous ß-galactosidase activity found
in nontransfected control tissue.
The accuracy of the method developed was confirmed
in transfection experiments performed in vivo in a pig
model. Uncorrected ß-galactosidase enzyme activity
demonstrated false-positive transfer efficiencies. In con-
trast, the ß-galactosidase activities in transfected arteries
corrected for blood content correlated well with results
obtained by RT-PCR.
Knowledge of the major factors, which potentially
could cause errors in the measurement of ß-galactosidase
enzyme activity, permits more accurate analysis of ex-
pression of this commonly used reporter gene. This proce-
dure may be particularly helpful in the cardiovascular
field, where usually low gene transfer rates and expression
are achieved.
ß-Galactosidase Activity in the Presence of
Blood
J Vasc Res 2000;37:585–593 593
In conclusion, this method represents a reliable tech-
nique for the evaluation of vascular in vitro and in vivo
gene transfer experiments with the ß-galactosidase report-
er gene in the presence of blood, especially where low
transfection efficiency may be expected.
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